Position in ENTA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$479,876
-$151,160 QoQ
Shares Held
37,995
-5.0% QoQ
Ownership
0.131%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRUDENTIAL FINANCIAL INC holds $507,740,529 across 170 Biotechnology names. ENTA ranks #89 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,491 | $108,548,965 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
131,560 | $58,746,801 | |
| 3 | INCY |
Incyte Corp
|
374,280 | $35,227,233 | |
| 4 | EXEL |
Exelixis, Inc.
|
463,825 | $19,893,454 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
64,133 | $12,804,153 | |
| 6 | ALMS |
Alumis Inc.
|
538,733 | $11,868,287 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
164,570 | $11,212,154 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
95,235 | $10,037,769 |
All Filings in ENTA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $479,876 | 37,995 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $631,036 | 40,015 | Shares | Defined | 2026-02-13 | |
| 2024-12-31 | $347,093 | 60,364 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,627,183 | 157,064 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,037,120 | 157,064 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,007,729 | 172,264 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,821,437 | 193,564 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,011,314 | 180,064 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $690,192 | 32,252 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,738,879 | 42,999 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $918,723 | 19,749 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,024,380 | 19,749 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $892,883 | 18,889 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,373,346 | 19,294 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,432,410 | 19,155 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,102,682 | 19,410 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $859,955 | 19,540 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,013,328 | 20,546 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $880,268 | 20,909 | Shares | Defined | 2021-08-16 | |
| 2020-09-30 | $1,078,073 | 23,549 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,069,573 | 21,302 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $1,314,859 | 25,566 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||